Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.
| Current Price | ₹122.79 |
|---|---|
| Market Cap | ₹579 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services > Pharmaceutical Manufacturing Equipment |
| P/E Ratio | 13.1 |
| Return on Equity | 9.14% |
| 52-Week Range | ₹121.60 – ₹262.80 |
| Beta (1Y) | 0.46 |
| Dividend Yield | 0.46% |
| Revenue | ₹75 Cr |
|---|---|
| Net Profit | ₹4 Cr |
| EPS (Basic) | ₹0.95 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Surgical & Medical Equipment-100%
Fabtech Technologies Limited is trading at ₹122.79, with a market capitalisation of ₹579 Cr.
Fabtech Technologies Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services > Pharmaceutical Manufacturing Equipment).
Fabtech Technologies Limited has a P/E of 13.1 and a return on equity of 9.14%.
In Q1 FY27, Fabtech Technologies Limited reported revenue of ₹75 Cr and net profit of ₹4 Cr, with basic EPS of ₹0.95 (consolidated, parsed from the company's exchange filing).